For the Inventor, By the Inventor

Enter assignee name

Dublin, Ireland

Bausch + Lomb Ireland Limited

Calculating rank

USPTO Granted Patents = 48

EPO Patents = 12

Trademarks = 20

Forward Citations = 16

Loading Chart...

Loading Chart...

89 inventors (with patents filed for the assignee):

Yehuda Ivri (14 out of 16 patents)

Alok Kumar Awasthi (11 out of 29 patents)

Jade J Russell (8 out of 8 patents)

4. Daniel V Palanker (6 out of 83 patents)

5. Mark R Mis (6 out of 37 patents)

6. Mark S Blumenkranz (5 out of 65 patents)

7. James Anthony DiBella, Jr (5 out of 8 patents)

8. Reynaldo J Quintana (5 out of 25 patents)

9. Kristen Hovinga (5 out of 5 patents)

10. Vicki Barniak (4 out of 11 patents)

11. William T Reindel (4 out of 5 patents)

12. Feng-Yang Shih (4 out of 4 patents)

13. Catherine Scheuer (4 out of 4 patents)

14. Andrew J Hoteling (3 out of 7 patents)

15. Emily A Gabriel (3 out of 6 patents)

Core Competencies:

Occlusion Detection

Contact Lens

Ocular Drug Delivery

Ophthalmic Suspension

Hydrodynamic Dispensing

Polymer Grafting

Multi-Dose System

Topical Delivery

Biomedical Devices

Ophthalmic Lens

Packaging Solutions

Crystalline Formulations

48 patents: Sort by Forward Citations

1. 12766033 - Phacoemulsification handpiece (2026-10-20),

2. 12741078 - Occlusion detection in vacuum-based ophthalmic surgical systems (2026-09-22),

3. 12734773 - Method for preparing a contact lens containing deprotected ultraviolet blockers (2026-09-15),

4. 12728090 - Eye formulations (2026-09-08),

5. 12655286 - Grafted polymer and use thereof (2026-06-16),

6. 12631791 - Multifunctional crosslinking agents and ophthalmic devices formed therefrom (2026-05-19),

7. 12611326 - Hydrodynamically actuated preservative free dispensing system having a collapsible liquid reservoir (2026-04-28),

8. 12600702 - Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile and formulations thereof (2026-04-14),

9. 12594251 - Benzalkonium chloride foruse in treating conjunctivitis and/or covid-19 (2026-04-07),

10. 12589069 - Ophthalmic suspension composition (2026-03-31),

11. 12582742 - Packaging solutions (2026-03-24),

12. 12575925 - Intraocular lens injector apparatus (2026-03-17),

13. 12564602 - Contact lens treating solution (2026-03-03),

14. 12558350 - COMPOSITIONS AND METHODS FOR TREATMENT (2026-02-24),

15. 12552883 - Ophthalmic devices (2026-02-17),

Company Overview

Bausch + Lomb Ireland Limited is a prominent player in the healthcare sector, focusing on the development and manufacturing of innovative eye health products. The company specializes in a wide range of offerings, including contact lenses, lens care products, and surgical devices aimed at enhancing vision and eye care. With a commitment to advancing ocular health, Bausch + Lomb leverages cutting-edge research and technology to deliver solutions that meet the diverse needs of patients and healthcare professionals globally.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

48 Patents

#40 in Dublin

#66 in Ireland

#14,561 in the World

Dublin, Ireland

Bausch + Lomb Ireland Limited

Forward Citations = 16

89 inventors:

Yehuda Ivri (14 out of 16 patents)

Alok Kumar Awasthi (11 out of 29 patents)

Jade J Russell (8 out of 8 patents)

4. Daniel V Palanker (6 out of 83 patents)

5. Mark R Mis (6 out of 37 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bausch + Lomb Ireland Limited. Retrieved from https://idiyas.com/company/bausch-plus-lomb-ireland

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…